Cargando…
Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
Attaching a cytotoxic “payload” to an antibody to form an antibody–drug conjugate (ADC) provides a mechanism for selective delivery of the cytotoxic agent to cancer cells via the specific binding of the antibody to cancer-selective cell surface molecules. The first ADC to receive marketing authoriza...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427099/ https://www.ncbi.nlm.nih.gov/pubmed/28361465 http://dx.doi.org/10.1007/s12325-017-0519-6 |